Tag: Eumentis Therapeutics

Eumentis Therapeutics has filed a notice of an exempt offering of securities to raise $2,000,000.00 in New Debt Financing.

Eumentis Therapeutics has filed a notice of an exempt offering of securities to raise $2,000,000.00 in New Debt Financing.

According to filings with the U.S. Securities and Exchange Commission, Eumentis Therapeutics is raising up to $2,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Mark Tepper…

Read More Read More

Eumentis Therapeutics has filed a notice of an exempt offering of securities to raise $20,000,000.00 in New Debt Financing.

Eumentis Therapeutics has filed a notice of an exempt offering of securities to raise $20,000,000.00 in New Debt Financing.

According to filings with the U.S. Securities and Exchange Commission, Eumentis Therapeutics is raising $20,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Mark Tepper played a…

Read More Read More